These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2996 related articles for article (PubMed ID: 17206982)
1. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
2. Rituximab for the treatment of diffuse large B-cell lymphomas. Held G; Pöschel V; Pfreundschuh M Expert Rev Anticancer Ther; 2006 Aug; 6(8):1175-86. PubMed ID: 16925484 [TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
5. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma. Collins-Burow B; Santos ES Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647 [TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma]. Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560 [TBL] [Abstract][Full Text] [Related]
7. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail]. Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Jazirehi AR; Bonavida B Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036 [TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy for indolent non-Hodgkin's lymphoma. Hagenbeek A; Czuczman MS; Ghielmini M; Herold M; Kimby E; Solal-Céligny P; Unterhalt M Anticancer Drugs; 2002 Nov; 13 Suppl 2():S11-7. PubMed ID: 12710586 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of rituximab in non-Hodgkin's lymphoma. Knight C; Maciver F Expert Rev Pharmacoecon Outcomes Res; 2007 Aug; 7(4):319-26. PubMed ID: 20528413 [TBL] [Abstract][Full Text] [Related]
11. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network. Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411 [TBL] [Abstract][Full Text] [Related]
12. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935 [TBL] [Abstract][Full Text] [Related]
13. [Rituximab]. Okamoto R; Maeda Y; Sasaki T Gan To Kagaku Ryoho; 2003 Aug; 30(8):1085-93. PubMed ID: 12938262 [TBL] [Abstract][Full Text] [Related]
14. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Reiter A; Klapper W Br J Haematol; 2008 Jul; 142(3):329-47. PubMed ID: 18537979 [TBL] [Abstract][Full Text] [Related]
18. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas. Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246 [TBL] [Abstract][Full Text] [Related]
19. CD20 positive childhood B-non Hodgkin lymphoma (B-NHL): morphology, immunophenotype and a novel treatment approach: a single center experience. Bilić E; Femenić R; Konja J; Simat M; Dubravcić K; Batinić D; Ries S; Rajić L Coll Antropol; 2010 Mar; 34(1):171-5. PubMed ID: 20432747 [TBL] [Abstract][Full Text] [Related]
20. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Grillo-López AJ; White CA; Varns C; Shen D; Wei A; McClure A; Dallaire BK Semin Oncol; 1999 Oct; 26(5 Suppl 14):66-73. PubMed ID: 10561020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]